Skip to main content

Clearday, Inc.

CLRDDelisted
Industry
Services-Nursing & Personal Care Facilities
SEC CIK
0000895665

Clearday, Inc. was delisted in 2025; its insiders filed their last Form 4 on Jan 3, 2023; no institution reported holding it in 13F filings for Q3 2025; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
0
Q3 2025
13F value
$0
Reported value at the end of Q3 2025
Superinvestors holding
0
At the end of Q3 2025

Superinvestors holding CLRD, Q3 2025

Go to the superinvestors tab

No superinvestor reported holding CLRD at the end of Q3 2025.

Latest insider trades

Open-market purchases and sales by Clearday, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 3, 2023 (view filing)Dec 30, 20224 daysWalesa JamesChief Executive OfficerPPurchase+1.78M$0.68+$1.21M+139.1%3.05M after
Jun 14, 2022 (view filing)Jun 104 daysWalesa JamesChief Executive OfficerPPurchase+157.4K––+14.1%1.28M after
Jun 14, 2022 (view filing)Jun 104 daysParrish Billie JayChief Operating OfficerPPurchaseCommon Stock, par value $0.001 per share+13.0K––+4.5%303.6K after
Jun 14, 2022 (view filing)Jun 104 daysChanning Alan HDirectorPPurchaseCommon Stock, par value $0.001 per share+24.5K––+23.6%128.2K after
Dec 20, 2021 (view filing)Dec 16-204 daysWalesa JamesChief Executive OfficerPPurchase+4.12K$3.02+$12.4K+0.4%1.12M after3 lots
Dec 16, 2021 (view filing)Dec 14-152 daysWalesa JamesChief Executive OfficerPPurchase+4.00K$3.09+$12.3K+0.4%1.12M after2 lots
Dec 14, 2021 (view filing)Dec 10-134 daysWalesa JamesChief Executive OfficerPPurchase+4.00K$3.06+$12.2K+0.4%1.11M after2 lots
Dec 9, 2021 (view filing)Dec 8-91 dayWalesa JamesChief Executive OfficerPPurchase+4.00K$3.01+$12.0K+0.4%1.11M after2 lots

Top 10 13F holders, Q3 2025

The largest institutional positions in Clearday, Inc. at the end of Q3 2025; share changes are against Q2 2025.

View all: Top 10 13F holders, Q3 2025

No institution reported holding CLRD in 13F filings for Q3 2025.